A Phase I/II Trial Of STI571 [imatinib] In Children With Newly Diagnosed Poor Prognosis Brainstem Gliomas And Recurrent Intracranial Malignant Gliomas.
Phase of Trial: Phase I/II
Latest Information Update: 18 Oct 2017
At a glance
- Drugs Imatinib (Primary)
- Indications Glioma
- Focus Adverse reactions; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 13 Apr 2010 Actual patient number (85) added as reported by ClinicalTrials.gov.
- 13 Apr 2010 Status changed from completed to discontinued as reported by ClinicalTrials.gov.